Navigation Links
Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
Date:10/22/2007

LEXINGTON, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that David B. Sharrock has elected to retire from its board of directors.

"I want to thank David for the many contributions he has made to Indevus during his more than 12 years of service to the Company," said Glenn L. Cooper, M.D., chairman and chief executive officer of Indevus. "David has provided invaluable guidance to the Company as we have moved from a development-stage company toward a specialty pharmaceutical company with several marketed products. All of us at Indevus are grateful to David and we wish him the best."

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) XR and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate cancer, SUPPRELIN(R) LA, for central precocious puberty, and DELATESTRYL(R) to treat male hypogonadism. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(R) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and pagoclone for stuttering.

Forward Looking Statements

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results and fi
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Applied Biosystems, part of Life Technol...ovative life science research and discovery soluti...generation genomic analysis, the SOLiD™ Syst...the Year for 2008 by The Scientist, a leading scie...ustry. In making the announcement of the first-eve...
(Date:12/3/2008)... Dec. 3 ev3 Inc. (Nasdaq... today announced the appointment of John,L. Miclo... , Mr. Miclot is currently the president an...tely held nationwide provider of various home care...wound care, urology and respiratory,disorders. P...
(Date:12/3/2008).... 3 CeloNova BioSciences, Inc., an...hich it is commercializing the,CATANIA(TM) Corona...tent,system that has not had any stent thrombosis...le for purchase throughout Europe and now some Mid...expansion ongoing. Concurrently,CeloNova notes t...
(Date:12/3/2008)...Dennis will Outline How Technology Can Solve Press... , , KINGSTON, ON, Dec. 3 /PRNewswire/ - Dr...c. (PPI), is one of four leading experts speaking ...ge Conference underway in Poznan , Poland. Dr. Den...lems in the 20th Century and the role it will play...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5ev3 Inc. Appoints John L. Miclot to Board of Directors 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3Leading Canadian Scientist to speak at UN Climate Change Conference 2
...nc., a developer of e-Business, Open Systems and I...y that it has been awarded the IBM Lotus Beacon Aw...e CommunityCard System. , ,The CommunityCard Syste...collaboration with Catholic Charities to help mana... swipe card. The system, currently installed at se...
...ted Wendel Barr to the position of president, earl...to the position of president, early development, i...ports the regional decision-making employed by its...otion, Wendel and Tony have become corporate senio...ys Global Leadership Council. , ,"In contrast to o...
...personalized print technology, a physicians group ...to retain patients. Instead of waiting for patient...ysicians are sending personalized messages by mail...ings -- and seeing response rates of 10 to 21 perc...work, worked with Customer Potential Management (C...
...ta Dental Plan of New Jersey and announced an inve... by Aetna, Ameritas Life Insurance Corp., Delta De... Company of America, MetLife and Dental Benefit Pr...up). , ,These companies have joined together in a ...rm that allows dentists to submit claims and pre-t...
Other Biology Technology:Computech Honored with Prestigious IBM Lotus Beacon Award 2Covance Appoints Co-Presidents for Early Development Services 2CPM Helps Physicians Group Retain Patients with New Kind of House Call 2
(Date:12/3/2008)...2008. The first 5-year forest inventory report for...lable to the public: California,s Forest Resources...is Report., Here are some key findings from the r...ate,s 100 million acres;19 million acres is public...interface account for most of the housing growth i...
(Date:12/3/2008)...h they may not help improve a person,s golf game, ...ink about the local country club in the near futur..., "There are more than 17,000 golf courses in the...at land is not used for playing," said Ray Semlits...ge of Arts and Science. "These managed green space...
(Date:12/3/2008)... -- As the United States continues to develop alte...ependence, cellulosic-based ethanol has emerged as... Corn stover remains the most popular source avail...sociated with the removal of corn fodder as a cell...vironmental concern. , In the November-Decembe...
(Date:12/3/2008)...ldren failing to take their medication for a range... part of a new university research project. , Th...he University of Nottingham and The University of ...hildren with asthma, diabetes, congenital heart di...t prevent them from taking medicines prescribed fo...
Breaking Biology News(10 mins):Forest inventories in California include more than trees 2Forest inventories in California include more than trees 3Golf course: Playing fields, wildlife sanctuaries or both 2Managing carbon loss 2A spoonful of sugar? 2A spoonful of sugar? 3Bond Laboratories First Quarter Fiscal 2008 Sales Exceeding Internal Projections 15283 1Bond Laboratories First Quarter Fiscal 2008 Sales Exceeding Internal Projections 15283 2Modern Healthcare Names Marshall Erdman Nations Top Design Build Company 15281 1Modern Healthcare Names Marshall Erdman Nations Top Design Build Company 15281 2Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement 15279 1Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement 15279 2Aida Acquires High Level Research Institute in China 4218 1Aida Acquires High Level Research Institute in China 4218 2
... of The Journal of Experimental Medicine identifie...f developing active tuberculosis (TB). Pedro Flor... of Texas Health Center (Tyler, TX) studied groups...dividuals who carry this genetic change were more ...using bacteria. , Infections with Mycobacterium tu...
...ook routinely inside the body and see -- at the le...istant dream. But in a series of experiments with ... from the Howard Hughes Medical Institute (HHMI) a...en a key step toward realizing that vision by demo...invasively and see the immune system at work. , Th...
...ook routinely inside the body and see -- at the le...istant dream. But in a series of experiments with ... from the Howard Hughes Medical Institute (HHMI) a...en a key step toward realizing that vision by demo...invasively and see the immune system at work. , Th...
... leads, no person has managed to live much longer ...dern age may have extended the average human life ...evity. One prominent theory of aging lays the blam...oteins by “free radicals,?highly reactive molecule...ia. , This damage is expected to reduce gene expre...
Other Biology News:Gene increases risk of tuberculosis 2Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 2Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method 3PET imaging reveals the immune system at work 2PET imaging reveals the immune system at work 3Carnegie Mellon scientists create PNA molecule with potential to build nanodevices 2
...for Membrane Proteins ,Contains sufficient compon...tracts for 2-D gel analysis , ,Includes:, , Mem-P...(contains sufficient reagents for extracting 25 ce...0 mg each) Kit , 2-D PAGEprep Protein Clean-up an...
...r-fluorescein is a hairpin primer labeled with a f...on-fluorescent quencher) and a 3 single-stranded o...o the UniPrimer provided in the Amplifluor Univers...oncentration of 5.0 M.,Fluorescence (Linear:Hair...
Propidium Iodide from Calbiochem
Mouse monoclonal antibody raised against a partial recombinant EBI3. NCBI Entrez Gene ID = EBI3
Biology Products: